Loading the player...
Closed Captioning / Subtitles Available
Information
TMS, Ketamine, Psychedelics, and More: Emerging Treatments and their Applications in Integrative Pediatric Psychiatry
Copyright :
Depression is the leading cause of disability worldwide and nearly 1/3 of patients do not find relief with antidepressant medications. Clinicians and patients desperately need more effective, safe treatment options. TMS, ketamine, and psychedelics are breakthrough interventions that are bringing hope for people suffering from treatment-resistant mental health conditions. This session will discuss the evolution of these treatments and give you tools to use them in an integrative approach to helping your patients.
Erin Amato, MD
Erin Amato, MD, is a double board-certified child, adolescent, and adult psychiatrist with Montana Psychiatry & Brain Center in Billings, Montana. She is also a fellow of anti-aging, metabolic and functional medicine through the Metabolic Medical Institute of A4M, and a fellow of the Integrative Psychiatry Institute. She is passionate about finding cutting-edge, innovative ways to prevent and treat mental health disorders that have not responded to traditional interventions. She is on the board of the American Society of Ketamine Physicians, Psychotherapists, and Practitioners and has overseen the administration of thousands of IV ketamine and esketamine treatments since 2014. She received training in Transcranial Magnetic Stimulation (TMS) and other non-invasive brain modulation techniques at the Brain Stimulation Laboratory of Medical University of South Carolina and has been performing TMS for the treatment of depression since 2015. She completed training with the Psychedelic Research and Training Institute for ketamine and psychedelic therapy in 2020. She is an integrative psychiatrist who looks to blend traditional treatment tools, like medication and talk therapy, with functional medicine testing, nutritional supplementation, and lifestyle education to design personalized treatment approaches that target the root causes of illness.
Speaker Disclosures:
Financial: Dr. Erin Amato has employment relationships with Montana Psychiatry PLLC, the Mood Restoration Institute, and the Yellowstone Boys and Girls Ranch. She receives a speaking honorarium from Janssen Pharmaceuticals and a consulting fee from Turnwell Mental Health Network. Dr. Amato receives a speaking honorarium from PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Dr. Erin Amato is a member of the American Academy of Anti-Aging Medicine, the American Society of Ketamine Physicians, the Clinical TMS Society, the Montana Medical Association, and the American Academy of Child and Adolescent Psychiatry.
